RETRACTED ARTICLE: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background Chronic intestinal inflammation alters host physiology and could lead to colorectal cancer (CRC). We have previously reported beneficial effects of the probiotic strain of Lactobacillus casei BL23 in different murine models of intestinal inflammation. In addition, there is an emerging interest on the potential beneficial effects of probiotics to treat CRC. We thus explored whether L. casei BL23 displays protective effects on CRC.Methods Mice were subcutaneously injected with 1,2-dimethylhydrazine (DMH) weekly during 10 weeks and orally administered with L. casei BL23 in the drinking water until the 10th week. Multiple plaque lesions in the large intestine were observed macroscopically and counted and intestinal tissues were also histologically analyzed. Finally, T-cell populations and cytokine production were evaluated after co-incubation of L. casei BL23 with spleen cells from non-treated mice to determine the immuno-modulatory effects of this bacterium.Results Our results show that oral treatment with this probiotic bacterium modulates host immune responses and significantly protect mice against DMH-induced CRC. This protection may be associated with the modulation of regulatory T-cells towards a Th17-biased immune response accompanied by the expression of regulatory cytokines (IL-6, IL-17, IL-10 and TGF-β), as demonstrated in L. casei BL23-treated splenocytes, but also with the colonic expression of IL-22 observed in vivo on L. casei BL23-treated mice; suggesting the induction of a fine-tune Th17-biased response.Conclusions Altogether our results reveal the high potential of L. casei BL23 to treat CRC and opens new frontiers for the study of immunomodulatory functions of probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been also reported in several studies that Lactobacilli may stimulate host’s immune cells such as NK cells or dendritic cells (DC) or TH1 response, which, in turn, leads to the elimination of cancerous or precancerous cells, although the exact bacterial bioproduct mediating such stimulatory effect still needs to be identified [45,46,47,48].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“method of Bradford [32].”
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050 · cited 1×
“Currently, some studies have demonstrated that both probiotic bacteria and gut microbiota [2] could be an alternative approach to prevent and treat a number of human diseases including cancer and CRC [3, 4].”
BackgroundGasson, M. J. (1983) · Journal of Bacteriology · doi:10.1128/jb.154.1.1-9.1983 · Cited by 1,322 · cited 7×
“Data are represented as individual tumors volumes from mice at the end of week 10 (median of the size is shown by bars), Student’s t test, *p\ 0.001 (A) (B) Microscopic damage score Mo nth 3 Mo nth 4 Mo nth 5 Mo nth 6 0 2 4 6 8 10 12 DMH L. lactis MG1363 L. casei BL23 M ic ro sc op ic s co re ** MPL Mo nth 3 Mo nth 4…”
MethodInfluentialTosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146 · cited 1×
“and an increase in Treg populations are most related to a beneficial effect in cancer (including CRC) [39–42].”
BackgroundLin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
The microbiota regulates type 2 immunity through RORγt + T cells
Ohnmacht, C., Park, J.-H., Cording, S., Wing, J. B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., et al. (2015) · Science · doi:10.1126/science.aac4263 · Cited by 863
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
Madsen, K. L., Doyle, J. S., Jewell, L. D., Tavernini, M. M., & Fedorak, R. N. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70013-2 · Cited by 761 · cited 3×
“For example, it has been reported that administration of Lactobacillus reuteri prevented colitis in IL-10 KO mice by increasing the number of LAB in the GIT [7].”
BackgroundDe Simone, V, Franzè, E., Ronchetti, G., Colantoni, A., Fantini, M. C., Di Fusco, D., Sica, G. S., Sileri, P., MacDonald, T. T., Pallone, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.286 · Cited by 595
Sawa, S., Lochner, M., Satoh-Takayama, N., Dulauroy, S., Bérard, M., Kleinschek, M., Cua, D., Di Santo, J. P., & Eberl, G. (2011) · Nature Immunology · doi:10.1038/ni.2002 · Cited by 568
Developmental plasticity of Th17 and Treg cells
Lee, Y. K., Mukasa, R., Hatton, R. D., & Weaver, C. T. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.021 · Cited by 423 · cited 1×
“In this context, recent observations put the light on the Treg/Th17 plasticity paradigm, suggesting that a response to specific-stimuli might be adjustable to environmental conditions [44].”
BackgroundSafety assessment of dairy microorganisms: The Lactobacillus genus
Bernardeau, M., Vernoux, J. P., Henri-Dubernet, S., & Guéguen, M. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.08.015 · Cited by 384 · cited 1×
“Also, some strains of lactobacilli are used for the production of yogurt, cheese, beer, wine, cider and other fermented foods, as well as animal feeds, such as silage [6].”
BackgroundProtumor vs Antitumor Functions of IL-17
Murugaiyan, G., & Saha, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901017 · Cited by 369
Reddy, B. S., & Rivenson, A. (1993) · PubMed · Cited by 357
Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice
O'Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O'Sullivan, G., Shanahan, F., & Collins, J. K. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01027.x · Cited by 298 · cited 1×
“salivarius UCC118 reduced prevalence of mucosal inflammatory activity and CRC in IL-10 KO mice by modifying the intestinal microbiota in these animals [15].”
BackgroundRole of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 270 · cited 4×
“Thus, manipulating the abnormal intestinal microbiota to decrease the more pathogenic species and enhance the concentration and metabolic activity of the beneficial species could be an alternative therapy for IBD [13, 14].”
BackgroundSelf-citationThe role of probiotic bacteria in cancer prevention
Hirayama, K., & Rafter, J. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00357-9 · Cited by 267 · cited 1×
“In addition, some LAB and their metabolites have been shown to inhibit the proliferation of tumor cells by direct or indirect interactions [21–23].”
BackgroundPotential role of probiotics on colorectal cancer prevention
Uccello, M., Malaguarnera, G., Basile, F., D’agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., & Biondi, A. (2012) · BMC Surgery · doi:10.1186/1471-2482-12-s1-s35 · Cited by 233 · cited 1×
“Currently, some studies have demonstrated that both probiotic bacteria and gut microbiota [2] could be an alternative approach to prevent and treat a number of human diseases including cancer and CRC [3, 4].”
BackgroundThe potential mechanisms involved in the anti-carcinogenic action of probiotics
Commane, D., Hughes, R., Shortt, C., & Rowland, I. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.027 · Cited by 204 · cited 1×
“In addition, some LAB and their metabolites have been shown to inhibit the proliferation of tumor cells by direct or indirect interactions [21–23].”
BackgroundInhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity
Liu, Y., Wang, L., Predina, J., Han, R., Beier, U. H., Wang, L.-C. S., Kapoor, V., Bhatti, T. R., Akimova, T., Singhal, S., et al. (2013) · Nature Medicine · doi:10.1038/nm.3286 · Cited by 201 · cited 1×
“7d) seem contradictory to the reported anticancer effects of this T-cell population [41], a recent study has described how impairment in Foxp3? Treg promotes anti-tumor immunity [43].”
BackgroundThe Role of Probiotic Cultures in the Prevention of Colon Cancer
Brady, L. J., Gallaher, D. D., & Busta, F. F. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.410s · Cited by 192 · cited 1×
“The results of in vitro assays, animal studies, and human clinical trials have demonstrated that some strains of lactobacilli and their fermented products (such as yogurt) could reduce the risks of certain types of cancer and inhibit the growth of certain tumors [16–20].”
ResultBermúdez-Humarán, L. G., Cortes-Perez, N. G., Lefèvre, F., Guimarães, V., Rabot, S., Alcocer-Gonzalez, J. M., Gratadoux, J.-J., Rodriguez-Padilla, C., Tamez-Guerra, R. S., Corthier, G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7297 · Cited by 191 · cited 2×
“Establishment of tumors was performed using an HPV16 tumor model in which injection of a mouse (C57BL/6) lung tumor line TC-1 provokes lethal tumors as previously described [29].”
MethodSelf-citationGounaris, E., Blatner, N. R., Dennis, K., Magnusson, F., Gurish, M. F., Strom, T. B., Beckhove, P., Gounari, F., & Khazaie, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0304 · Cited by 189
Anti-carcinogenicity of probiotics and prebiotics.
Burns, A. J., & Rowland, I. R. (2000) · PubMed · Cited by 188
Complete Genome Sequence of the Probiotic Lactobacillus casei Strain BL23
Mazé, A., Boël, G., Zúñiga, M., Bourand-Plantefol, A., Loux, V., Yebra, M. J., Monedero, V., Correia, K., Jacques, N., Beaufils, S., et al. (2010) · Journal of Bacteriology · doi:10.1128/jb.00076-10 · Cited by 175 · cited 1×
“Lactobacillus casei BL23 [27] was grown in MRS medium (Difco, USA) at 37 C without shaking.”
MethodCha, H.-R., Chang, S.-Y., Chang, J.-H., Kim, J.-O., Yang, J.-Y., Kim, C.-H., & Kweon, M.-N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902944 · Cited by 165 · cited 2×
“IL-22 fwd 50 CATGCAGGAGGTGGTACCTT 30 rev 50 CAGACGCAAGCATTTCTCAG 30 [36]”
BackgroundAntimutagenic properties of probiotic bacteria and of organic acids
Lankaputhra, W. E. V., & Shah, N. P. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00208-x · Cited by 158 · cited 1×
“The results of in vitro assays, animal studies, and human clinical trials have demonstrated that some strains of lactobacilli and their fermented products (such as yogurt) could reduce the risks of certain types of cancer and inhibit the growth of certain tumors [16–20].”
ResultPrevention of colon cancer by pre- and probiotics: evidence from laboratory studies
Reddy, B. S. (1998) · British Journal of Nutrition · doi:10.1017/s0007114500006061 · Cited by 152 · cited 1×
“The results of in vitro assays, animal studies, and human clinical trials have demonstrated that some strains of lactobacilli and their fermented products (such as yogurt) could reduce the risks of certain types of cancer and inhibit the growth of certain tumors [16–20].”
ResultAbating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid
Khazaie, K., Zadeh, M., Khan, M. W., Bere, P., Gounari, F., Dennis, K., Blatner, N. R., Owen, J. L., Klaenhammer, T. R., & Mohamadzadeh, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207230109 · Cited by 148 · cited 1×
“, including anti-inflammatory [7, 8] and anti-cancer [8–12] activities.”
de Moreno de LeBlanc, A., LeBlanc, J. G., Perdigón, G., Miyoshi, A., Langella, P., Azevedo, V., & Sesma, F. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47403-0 · Cited by 143
Self-citationProbiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives
Kahouli, I., Tomaro-Duchesneau, C., & Prakash, S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.048975-0 · Cited by 142 · cited 1×
“Currently, some studies have demonstrated that both probiotic bacteria and gut microbiota [2] could be an alternative approach to prevent and treat a number of human diseases including cancer and CRC [3, 4].”
BackgroundRochat, T., Bermúdez-Humarán, L., Gratadoux, J.-J., Fourage, C., Hoebler, C., Corthier, G., & Langella, P. (2007) · Microbial Cell Factories · doi:10.1186/1475-2859-6-22 · Cited by 135 · cited 1×
“casei BL23, in two different models of chemically-induced colitis in mice [24, 25].”
BackgroundSelf-citationKato, I., Endo, K., & Yokokura, T. (1994) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)90116-3 · Cited by 130 · cited 1×
“, including anti-inflammatory [7, 8] and anti-cancer [8–12] activities.”
Hu, J., Wang, C., Ye, L., Yang, W., Huang, H., Meng, F., Shi, S., & Ding, Z. (2015) · Journal of Biosciences · doi:10.1007/s12038-015-9518-4 · Cited by 124
The application of probiotic fermented milks in cancer and intestinal inflammation
de Moreno de LeBlanc, A., & Perdigón, G. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s002966511000159x · Cited by 113
LeBlanc, A. D. M. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16518 · Cited by 101 · cited 1×
“Thus, manipulating the abnormal intestinal microbiota to decrease the more pathogenic species and enhance the concentration and metabolic activity of the beneficial species could be an alternative therapy for IBD [13, 14].”
BackgroundAragón, F., Carino, S., Perdigón, G., & de Moreno de LeBlanc, A. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000079 · Cited by 92 · cited 1×
“, including anti-inflammatory [7, 8] and anti-cancer [8–12] activities.”
Aragón, F., Carino, S., Perdigón, G., & de Moreno de LeBlanc, A. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.02.005 · Cited by 89
Yang, M., Yang, C., & Mine, Y. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03442.x · Cited by 86 · cited 1×
“TGF-b fwd 50 TTGCTTCAGCTCCACAGAGA 30 rev 50 TACTGTGTGTCCAGGCTCCA 30 [35]”
BackgroundRibelles, P., Benbouziane, B., Langella, P., Suárez, J. E., Bermúdez‐Humarán, L. G., & Riazi, A. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4575-1 · Cited by 58 · cited 3×
“casei BL23-closely related strain) had anti-tumoral effects in the TC-1 mouse allograft model of HPV-induced cancer [26].”
BackgroundSelf-citationIL-4 regulates susceptibility to intestinal inflammation in murine food allergy
Cardoso, C. R. D. B., Provinciatto, P. R., Godoi, D. F., Ferreira, B. R., Teixeira, G. A. P. B., Rossi, M. A., Cunha, F. Q., & Silva, J. S. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90431.2008 · Cited by 48 · cited 1×
“b-actin fwd 50 AGCTGCGTTTTACACCCTTT 30 rev 50 AAGCCATGCCAATGTTGTCT 30 [37]”
BackgroundSantiago, C., Pagán, B., Isidro, A., & Appleyard, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1418 · Cited by 41
Hazebrouck, S., Przybylski‐Nicaise, L., Ah-Leung, S., Adel‐Patient, K., Corthier, G., Langella, P., & Wal, J. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.064 · Cited by 30
Self-citationMason, K. M., Bigley, N. J., & Fink, P. S. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00200-7 · Cited by 11 · cited 1×
“In vitro experiments were performed using fresh naı̈ve mouse spleen cells, as previously described [33] with some modifications.”
Method
Cited by
Probiotic species in the modulation of gut microbiota: An overview
Azad, M. A. K., Sarker, M., Li, T., & Yin, J. (2018) · BioMed Research International · doi:10.1155/2018/9478630 · Cited by 803
“casei BL23 Female C57BL/6 mice CRC ↑Th17, Th 22, IL-10, and IL-22 ↓ Treg [19, 20]”
BackgroundAdhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health
Monteagudo-Mera, A., Rastall, R. A., Gibson, G. R., Charalampopoulos, D., & Chatzifragkou, A. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09978-7 · Cited by 743
“Conversely, probiotic bacteria could suppress pathogenic Th17 cells and induce steady-state Th17 cells (Lenoir et al. 2016).”
BackgroundGut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
“While downregulation of proinflammatory cytokines (MCP-1, TNF-α) and upregulation of IL-10 is observed in intestinal content, splenocyte analysis has demonstrated the decreased Treg level and increased Th17 population at the systemic level, thus triggering a Th17/Treg mixed-type immune response [31].”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
Anticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Metadata
- Authors
- Lenoir, M., del Carmen, S., Cortes-Perez, N. G., Lozano-Ojalvo, D., Muñoz-Provencio, D., Chain, F., Langella, P., de Moreno de LeBlanc, A., LeBlanc, J. G., & Bermúdez-Humarán, L. G.
- Affiliations
- AgroParisTech (FR)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- LeBlanc, Jean Guy
- Venue
- Journal of Gastroenterology
- Published
- 2016-01-09
- Volume
- 51
- Issue
- 9
- Pages
- 862-873
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2227234059
- Cited by
- 155
- References
- 46
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 15 · 2021: 17 · 2020: 35 · 2019: 23 · 2018: 17 · 2017: 17 · 2016: 4
- FWCI
- 25.61
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2020-09-08)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Ministerio de Educación, Cultura y Deporte
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, colorectal cancer, 1,2-dimethylhydrazine, regulatory T cells, Th17 cells, immunomodulation, intestinal inflammation, IL-22, IL-17, IL-10, TGF-beta, interleukin-6, retracted article
- MeSH terms
- Animals, Female, Lacticaseibacillus casei, Mice, Inbred BALB C, Mice, Inbred C57BL, Colorectal Neoplasms, Biomarkers, Cytokines, 1,2-Dimethylhydrazine, Probiotics, T-Lymphocytes, Regulatory, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.